
BRAF Mutation and Cancer - Johns Hopkins Medicine
A BRAF mutation is a spontaneous change in the BRAF gene that makes it work incorrectly. A mutation causes the gene to turn on the protein and keep it on, which means certain cells get ongoing signals to keep dividing and no instructions on when to stop.
BRAF Mutation: Cancer Types, Testing, Treatment - Verywell Health
2024年6月23日 · BRAF mutations are DNA changes in some cancer cells that can be treated with newer targeted therapies. BRAF mutations are found in roughly half of melanomas. Medications that target these mutations have significantly improved the survival rates of metastatic melanoma.
BRAF (gene) - Wikipedia
BRAF is a human gene that encodes a protein called B-Raf. The gene is also referred to as proto-oncogene B-Raf and v-Raf murine sarcoma viral oncogene homolog B, while the protein is more formally known as serine/threonine-protein kinase B-Raf. [5][6]
Emerging BRAF Mutations in Cancer Progression and Their …
In the human genome, the B-raf proto-oncogene (BRAF) gene is located on chromosome 7 (7q34) and encodes the BRAF protein, which is composed of 766 amino acids. While all RAF proteins can phosphorylate MEK (MEK1 and MEK2), BRAF has the strongest activation capacity.
BRAF and Lung Cancer - American Lung Association
BRAF is one type of lung cancer biomarker. BRAF is the name of both a gene and a protein. The BRAF protein helps control cell growth. When there is a mutation in the BRAF gene, it creates an abnormal protein that sends signals that lead to uncontrolled cell growth and cancer.
FDA approves dabrafenib–trametinib for BRAF-positive cancers
2022年7月21日 · Data from NCI-MATCH, ROAR trials informed approval Dabrafenib and trametinib block different growth-promoting signals in tumor cells that are activated by the V600E BRAF mutation. Dabrafenib inhibits signals from the BRAF protein, whereas trametinib inhibits signals from the MEK protein.
BRAF — a tumour-agnostic drug target with lineage-specific
2024年1月26日 · In this Review, we describe the biochemical basis for oncogenic BRAF-induced activation of MAPK signalling and pan-cancer and lineage-specific mechanisms of intrinsic, adaptive and acquired...
BRAF B-Raf proto-oncogene, serine/threonine kinase [ (human)]
Gene ID: 673, updated on 8-Feb-2025. This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion.
Molecular Pathways and Mechanisms of BRAF in Cancer Therapy
In this review, we identify the mechanics of RAF signaling through the RAS/MAPK pathway, present existing data on single-agent and combination RAF targeting efforts, describe emerging combinations, summarize the toxicity of the various agents in clinical testing, and speculate as to where the field may be headed.
BRAF Gene - GeneCards | BRAF Protein | BRAF Antibody
2024年12月24日 · BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase) is a Protein Coding gene. Diseases associated with BRAF include Lung Cancer and Cardiofaciocutaneous Syndrome 1. Among its related pathways are IL-9 Signaling Pathways and Prolactin Signaling.